Herzelia, Israel

Uri Einav

This inventor holds 1 USPTO granted patent. Top assignee: Microsoft Technology Licensing, LLC. Active years: 2026.


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Uri Einav: Innovator in Clinical Information Extraction

Introduction

Uri Einav is a notable inventor based in Herzelia, Israel. He has made significant contributions to the field of clinical information extraction through his innovative patent. His work focuses on enhancing the capabilities of generative artificial intelligence in analyzing clinical documents.

Latest Patents

Uri Einav holds a patent titled "Input augmentation for guiding generative applications in evidence-supported clinical information extraction." This patent outlines methods for augmenting text inputs to improve the analysis of clinical documents. The solutions include identifying clinical named entities within text, adding anchor tags with entity IDs and clinical attributes, and submitting enhanced input documents to generative AI models for further processing.

Career Highlights

Uri is currently employed at Microsoft Technology Licensing, LLC, where he applies his expertise in developing advanced technologies. His work at Microsoft reflects his commitment to improving clinical information systems and enhancing the efficiency of healthcare data analysis.

Collaborations

Uri collaborates with talented professionals such as Shahar Yekutiel and Ksenya Kveler. Their combined efforts contribute to the advancement of innovative solutions in the field of clinical information extraction.

Conclusion

Uri Einav's contributions to the field of clinical information extraction through his patent and work at Microsoft Technology Licensing, LLC, highlight his role as an innovator in healthcare technology. His efforts are paving the way for more efficient clinical data analysis and improved patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…